Neuroendocrine prostate cancer (NEPC) is an androgen receptor-negative prostate cancer subtype that can occur sporadically but most commonly evolves from primary prostate adenocarcinoma [69]. This evidence concerns the gene AR and prostate adenocarcinoma.